Small Molecule Drug Discovery Market 2027 By Therapeutic Area, Process/Phase, and Geography | The Insight Partners

Small Molecule Drug Discovery Market to 2027 - Global Analysis and Forecasts By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Other Therapeutic Areas); Process/Phase (Target Id/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization), and Geography

Report Code: TIPRE00004774 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity.

MARKET DYNAMICS
The small molecules drugs discovery market is anticipated to grow in the forecast period owing to increasing drug discovery, increased use of these drugs in treatment of chronic diseases and development across the globe. However, the rising demand of innovative and effective therapies, preference for small molecules and growing number of contract research organizations are likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Small Molecules Drugs Discovery Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of small molecules drugs discovery market with detailed market segmentation by therapeutic area, process/phase and geography. The global small molecules drugs discovery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global small molecules drugs discovery market is segmented on the basis of therapeutic area and process/phase. Based on therapeutic area, the market is classified as oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology and other therapeutic areas. On the basis of process/phase, the market is divided into target ID/ validation, hit generation & selection, lead identification and lead optimization.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global small molecules drugs discovery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The small molecules drugs discovery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting small molecules drugs discovery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the small molecules drugs discovery market in these regions.

MARKET PLAYERS
The reports cover key developments in the small molecules drugs discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from small molecules drugs discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for small molecules drugs discovery market in the global market. Below mentioned is the list of few companies engaged in the small molecules drugs discovery market.

The report also includes the profiles of key small molecules drugs discovery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Merck KGaA, Darmstadt
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Johnson and Johnson Services, Inc.
  • Gilead Sciences, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • ALLERGAN
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Small Molecule Drug Discovery Market - By Therapeutic Area
1.3.2 Small Molecule Drug Discovery Market - By Process/Phase
1.3.3 Small Molecule Drug Discovery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMALL MOLECULE DRUG DISCOVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMALL MOLECULE DRUG DISCOVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMALL MOLECULE DRUG DISCOVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. SMALL MOLECULE DRUG DISCOVERY - GLOBAL MARKET OVERVIEW
6.2. SMALL MOLECULE DRUG DISCOVERY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SMALL MOLECULE DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC AREA
7.1. OVERVIEW
7.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. CENTRAL NERVOUS SYSTEM
7.4.1. Overview
7.4.2. Central Nervous System Market Forecast and Analysis
7.5. CARDIOVASCULAR
7.5.1. Overview
7.5.2. Cardiovascular Market Forecast and Analysis
7.6. RESPIRATORY
7.6.1. Overview
7.6.2. Respiratory Market Forecast and Analysis
7.7. ORTHOPEDICS
7.7.1. Overview
7.7.2. Orthopedics Market Forecast and Analysis
7.8. IMMUNOLOGY
7.8.1. Overview
7.8.2. Immunology Market Forecast and Analysis
7.9. OTHER THERAPEUTIC AREAS
7.9.1. Overview
7.9.2. Other Therapeutic Areas Market Forecast and Analysis
8. SMALL MOLECULE DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - PROCESS/PHASE
8.1. OVERVIEW
8.2. PROCESS/PHASE MARKET FORECASTS AND ANALYSIS
8.3. TARGET ID/VALIDATION
8.3.1. Overview
8.3.2. Target Id/Validation Market Forecast and Analysis
8.4. HIT GENERATION AND SELECTION
8.4.1. Overview
8.4.2. Hit Generation and Selection Market Forecast and Analysis
8.5. LEAD IDENTIFICATION
8.5.1. Overview
8.5.2. Lead Identification Market Forecast and Analysis
8.6. LEAD OPTIMIZATION
8.6.1. Overview
8.6.2. Lead Optimization Market Forecast and Analysis
9. SMALL MOLECULE DRUG DISCOVERY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Small Molecule Drug Discovery Market Overview
9.1.2 North America Small Molecule Drug Discovery Market Forecasts and Analysis
9.1.3 North America Small Molecule Drug Discovery Market Forecasts and Analysis - By Therapeutic Area
9.1.4 North America Small Molecule Drug Discovery Market Forecasts and Analysis - By Process/Phase
9.1.5 North America Small Molecule Drug Discovery Market Forecasts and Analysis - By Countries
9.1.5.1 United States Small Molecule Drug Discovery Market
9.1.5.1.1 United States Small Molecule Drug Discovery Market by Therapeutic Area
9.1.5.1.2 United States Small Molecule Drug Discovery Market by Process/Phase
9.1.5.2 Canada Small Molecule Drug Discovery Market
9.1.5.2.1 Canada Small Molecule Drug Discovery Market by Therapeutic Area
9.1.5.2.2 Canada Small Molecule Drug Discovery Market by Process/Phase
9.1.5.3 Mexico Small Molecule Drug Discovery Market
9.1.5.3.1 Mexico Small Molecule Drug Discovery Market by Therapeutic Area
9.1.5.3.2 Mexico Small Molecule Drug Discovery Market by Process/Phase
9.2. EUROPE
9.2.1 Europe Small Molecule Drug Discovery Market Overview
9.2.2 Europe Small Molecule Drug Discovery Market Forecasts and Analysis
9.2.3 Europe Small Molecule Drug Discovery Market Forecasts and Analysis - By Therapeutic Area
9.2.4 Europe Small Molecule Drug Discovery Market Forecasts and Analysis - By Process/Phase
9.2.5 Europe Small Molecule Drug Discovery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Small Molecule Drug Discovery Market
9.2.5.1.1 Germany Small Molecule Drug Discovery Market by Therapeutic Area
9.2.5.1.2 Germany Small Molecule Drug Discovery Market by Process/Phase
9.2.5.2 France Small Molecule Drug Discovery Market
9.2.5.2.1 France Small Molecule Drug Discovery Market by Therapeutic Area
9.2.5.2.2 France Small Molecule Drug Discovery Market by Process/Phase
9.2.5.3 Italy Small Molecule Drug Discovery Market
9.2.5.3.1 Italy Small Molecule Drug Discovery Market by Therapeutic Area
9.2.5.3.2 Italy Small Molecule Drug Discovery Market by Process/Phase
9.2.5.4 Spain Small Molecule Drug Discovery Market
9.2.5.4.1 Spain Small Molecule Drug Discovery Market by Therapeutic Area
9.2.5.4.2 Spain Small Molecule Drug Discovery Market by Process/Phase
9.2.5.5 United Kingdom Small Molecule Drug Discovery Market
9.2.5.5.1 United Kingdom Small Molecule Drug Discovery Market by Therapeutic Area
9.2.5.5.2 United Kingdom Small Molecule Drug Discovery Market by Process/Phase
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Small Molecule Drug Discovery Market Overview
9.3.2 Asia-Pacific Small Molecule Drug Discovery Market Forecasts and Analysis
9.3.3 Asia-Pacific Small Molecule Drug Discovery Market Forecasts and Analysis - By Therapeutic Area
9.3.4 Asia-Pacific Small Molecule Drug Discovery Market Forecasts and Analysis - By Process/Phase
9.3.5 Asia-Pacific Small Molecule Drug Discovery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Small Molecule Drug Discovery Market
9.3.5.1.1 Australia Small Molecule Drug Discovery Market by Therapeutic Area
9.3.5.1.2 Australia Small Molecule Drug Discovery Market by Process/Phase
9.3.5.2 China Small Molecule Drug Discovery Market
9.3.5.2.1 China Small Molecule Drug Discovery Market by Therapeutic Area
9.3.5.2.2 China Small Molecule Drug Discovery Market by Process/Phase
9.3.5.3 India Small Molecule Drug Discovery Market
9.3.5.3.1 India Small Molecule Drug Discovery Market by Therapeutic Area
9.3.5.3.2 India Small Molecule Drug Discovery Market by Process/Phase
9.3.5.4 Japan Small Molecule Drug Discovery Market
9.3.5.4.1 Japan Small Molecule Drug Discovery Market by Therapeutic Area
9.3.5.4.2 Japan Small Molecule Drug Discovery Market by Process/Phase
9.3.5.5 South Korea Small Molecule Drug Discovery Market
9.3.5.5.1 South Korea Small Molecule Drug Discovery Market by Therapeutic Area
9.3.5.5.2 South Korea Small Molecule Drug Discovery Market by Process/Phase
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Small Molecule Drug Discovery Market Overview
9.4.2 Middle East and Africa Small Molecule Drug Discovery Market Forecasts and Analysis
9.4.3 Middle East and Africa Small Molecule Drug Discovery Market Forecasts and Analysis - By Therapeutic Area
9.4.4 Middle East and Africa Small Molecule Drug Discovery Market Forecasts and Analysis - By Process/Phase
9.4.5 Middle East and Africa Small Molecule Drug Discovery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Small Molecule Drug Discovery Market
9.4.5.1.1 South Africa Small Molecule Drug Discovery Market by Therapeutic Area
9.4.5.1.2 South Africa Small Molecule Drug Discovery Market by Process/Phase
9.4.5.2 Saudi Arabia Small Molecule Drug Discovery Market
9.4.5.2.1 Saudi Arabia Small Molecule Drug Discovery Market by Therapeutic Area
9.4.5.2.2 Saudi Arabia Small Molecule Drug Discovery Market by Process/Phase
9.4.5.3 U.A.E Small Molecule Drug Discovery Market
9.4.5.3.1 U.A.E Small Molecule Drug Discovery Market by Therapeutic Area
9.4.5.3.2 U.A.E Small Molecule Drug Discovery Market by Process/Phase
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Small Molecule Drug Discovery Market Overview
9.5.2 South and Central America Small Molecule Drug Discovery Market Forecasts and Analysis
9.5.3 South and Central America Small Molecule Drug Discovery Market Forecasts and Analysis - By Therapeutic Area
9.5.4 South and Central America Small Molecule Drug Discovery Market Forecasts and Analysis - By Process/Phase
9.5.5 South and Central America Small Molecule Drug Discovery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Small Molecule Drug Discovery Market
9.5.5.1.1 Brazil Small Molecule Drug Discovery Market by Therapeutic Area
9.5.5.1.2 Brazil Small Molecule Drug Discovery Market by Process/Phase
9.5.5.2 Argentina Small Molecule Drug Discovery Market
9.5.5.2.1 Argentina Small Molecule Drug Discovery Market by Therapeutic Area
9.5.5.2.2 Argentina Small Molecule Drug Discovery Market by Process/Phase
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SMALL MOLECULE DRUG DISCOVERY MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL-MYERS SQUIBB COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK KGAA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON SERVICES, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GILEAD SCIENCES, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ALLERGAN
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Bristol-Myers Squibb Company
3. Merck KGaA, Darmstadt
4. GlaxoSmithKline plc.
5. AstraZeneca
6. Johnson and Johnson Services, Inc.
7. Gilead Sciences, Inc.
8. Teva Pharmaceutical Industries Ltd.
9. Boehringer Ingelheim International GmbH
10. ALLERGAN